Aldeyra Therapeutics, Inc.
ALDXNASDAQHealthcareBiotechnology
As of Oct 27, 2026 close
- Market cap
- $38.68M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.65$5.93
- Volume (live)
- -
- Avg. volume (3M)
- 1.62M
Aldeyra Therapeutics (ALDX) Stock Price & Financial Analysis
Aldeyra Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.62 - $0.67 |
|---|---|
| 52-Week High | $5.93 |
| 52-Week Low | $0.65 |
| Open | $0.63 |
| Volume (last close) | 991.81K |
| Average Volume (3M) | 1.62M |
| 50-Day MA | $1.29 |
|---|---|
| 200-Day MA | $2.42 |
| 1-Year Change | −87.54% |
| Market Cap | 38.68M |
|---|---|
| Shares Outstanding | 60.32M |
| Price to Book (P/B) | 1.02 |
| EV/EBITDA | 0.28 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 27, 2026. Data sources and methodology
Aldeyra Therapeutics at a Glance
As of the Oct 27, 2026 close, Aldeyra Therapeutics (ALDX) has a market capitalization of $38.68M.
As of its latest reported balance sheet, it holds $45.09M in cash and securities against $143.45K of debt, a net cash position of $44.95M.
Aldeyra Therapeutics does not currently pay a dividend.
The share price is down 87.5% over the past year. At $0.64 (the Oct 27, 2026 close) it sits near the bottom of its 52-week range of $0.65 to $5.93, below its 200-day moving average of $2.42.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Aldeyra Therapeutics
What is the current stock price for ALDX?
As of the Oct 27, 2026 close, ALDX stock trades at $0.64. The 52-week range is $0.65–$5.93, with a day range of $0.62–$0.67.
What is the P/E ratio for ALDX?
The P/E ratio (Price-to-Earnings) for ALDX is shown in the Key Statistics section. This valuation metric helps compare Aldeyra Therapeutics, Inc. to industry peers.
Does ALDX pay dividends?
Aldeyra Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ALDX?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for ALDX is Buy.
What is the market cap of ALDX?
As of the Oct 27, 2026 close, Aldeyra Therapeutics's market capitalization is $38.7M, classifying it as a micro-cap company. Aldeyra Therapeutics operates in the Healthcare sector within the Biotechnology industry.